Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-10-03
2006-10-03
Canella, Karen A. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S828000, C530S829000
Reexamination Certificate
active
07115710
ABSTRACT:
The present invention relates to PTP05 polypeptides and PTP10 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for PTP05 and/or PTP10 related diseases or conditions characterized by an abnormal interaction between a PTP05 polypeptide and a PTP05 binding partner and/or a PTP10 polypeptide and a PTP10 binding partner.
REFERENCES:
patent: 4343940 (1982-08-01), Kreighbaum et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4447608 (1984-05-01), Jones et al.
patent: 4757072 (1988-07-01), Kabbe et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 5217999 (1993-06-01), Levitzki et al.
patent: 5283173 (1994-02-01), Fields et al.
patent: 5302606 (1994-04-01), Spada et al.
patent: 5316553 (1994-05-01), Kaul et al.
patent: 5330992 (1994-07-01), Eissenstat et al.
patent: 5602171 (1997-02-01), Tang et al.
patent: 5610173 (1997-03-01), Schwartz et al.
patent: 0 520 722 (1992-12-01), None
patent: 0 562 734 (1993-09-01), None
patent: 0 566 226 (1993-10-01), None
patent: 91/15495 (1991-10-01), None
patent: 92/20642 (1992-11-01), None
patent: 92/21660 (1992-12-01), None
patent: 93/09236 (1993-05-01), None
patent: 94/03427 (1994-02-01), None
patent: 94/14808 (1994-07-01), None
patent: 94/23039 (1994-10-01), None
patent: 96/22976 (1996-08-01), None
Patel et al, Journal of Biological Chemistry, 1999, vol. 274, pp. 7958-7968, abstract.
Kume et al, Journal of Biological Chemistry, 1996, vol. 271, pp. 30916-30921, abstract.
Li et al, Cell Signaling, 1996, vol. 8, pp. 467-473, abstract.
Xie et al, Cancer Research, 1996, vol. 56, pp. 2742=2744, abstract.
Partanen, Anticancer Research, 1996, vol. 16, pp. 943-946, abstract.
Tabiti et al, Cancer Letters, 1995, vol. 93, pp. 239-248, abstract.
Maekawa et al, FEBS Letters, 1994, vol. 337, pp. 200-206, abstract.
Jones et al (Journal of Biological Chemistry, 1989, vol. 264, pp. 7747-7753).
Ahmad et al (Journal of Clinical Investigation, 1995, vol. 85, pp. 2806-2812).
Norris et al (FEBS Letters, 1997, vol. 415, pp. 243-248).
Abe et al., “Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR5 Coupled to Inositol Pohosphate/Ca2+Signal,”J. Biol. Chem. 267(19):13361-13368 (1992).
Allen et al., “Modulation of CD4 by suramin,”Clin. Exp. Immunol. 91:141-146 (1991).
Altschul et al., “Basic Local Alignment Search Tool,”J. Mol. Biol. 215:403-410 (1990).
Anafi et al., “Tyrphostin-Induced Inhibition of p210bcr-ablTyrosine Kinase Activity Induces K562 to Differentiate,”Blood82:3524-3529 (1993).
Baker et al., “Induction of acetylcholine receptor clustering by native polystyrene beads,”Journal of Cell Science102:543-555 (1992).
Barker et al., “In vitroactivity of non-glutamate containing quinazoline-based thymidylate synthase inhibitors,”Proceedings of the American Association for Cancer Research32:327 at abstract No. 1939 (1991).
Bayer et al., “The Avidin-Biotin Complex in Affinity Cytochemistry,”Methods in Enzymology62:308-319 (1979).
Benoist and Chambon, “In vivosequence requirements of the SV40 early promoter region,”Nature290:304-310 (1981).
Bertino, “Toward Improved Selectivity in Cancer Chemotherapy: The Richard and Hinda Rosenthal Foundation Award Lecture,”Cancer Research39:293-304 (1979).
Bilder et al., “Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells,”Am. J. Physiol. 260(Cell Physiol.29):C721-C730 (1991).
Bollon and Stauver, “DNA Transformation Efficiency of Various Bacterial and Yeast Host-Vector Systems,”Journal of Clinical Hematology and Oncology10(2&3):39-48 (1980).
Botstein et al., “Making Mutationsin vitroand Putting Them Back into Yeast,”Miami Winter Symposia—From Gene to Protein: Translation into Biotechnology, edited by Ahma et al., Academic Press, 19:265-274 (1982).
Brinster et al., “Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs,”Proc. Natl. Acad. Sci. USA82:4438-4442 (1985).
Broach, “The Yeast Plasmid 2μ Circle,”Cell28:203-204 (1982).
Broach, “The Yeast Plasmid 2μ Circle,” inThe Molecular Biology of the Yeast Saccharomyces: Life Cycle and Inheritance, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 445-470 (1981).
Brunton et al., “Anti-tumour activity of novel tryphostins in breast cancer cells,”Proceedings of the American Association for Cancer Research33:558 at abstract No. 3335 (1992).
Bryckaert et al., “Inhibition of Platelet-Derived Growth Factor-Induced Mitogenesis and Tyrosine Kinase Activity in Cultured Bone Marrow Fibroblasts by Tyrphostins,”Exp. Cell Research199:255-261 (1992).
Bullock et al., “Techniques in Immunocytochemistry,” Academic Press, Orlando, FL: vol. 1 (1982), vol. 2 (1983), vol. 3 (1985) (Table of Contents Only).
Burke et al., “Arylamides of Hydroxylated Isoquinolines as Protein-Tyrosine Kinase Inhibitors,”Bioorganic&Medical Chemistry Letters2(12):1771-1774 (1992).
Burke et al., “Bicyclic Compounds as Ring-Constrained Inhibitors of Protein-Tyrosine Kinase p56ick 1,”Journal of Medicinal Chemistry36(4):425-432 (1993).
Campbell,Monoclonal Antibody Technology: Laboratory Techniques in Biochemistry and Molecular Biology, vol. 13, Elsevier Science Publishers, Amsterdam, The Netherlands (1984) (Table of Contents Only).
Capecchi, “Altering the Genome by Homologous Recombination,”Science244:1288-1292 (1989).
Capecchi, “High Efficiency Transformation by Direct Microinjection of DNA into Cultured Mammalian Cells,”Cell22:479-488 (1980).
Cenatiempo, “Prokaryotic gene expressionin vitro: transcription-translation coupled systems,”Biochimie68:505-515 (1986).
Chard,An-Introduction to Radioimmunoassay and Related Techniques, Elsevier Science Publishers, Amsterdam, The Netherlands (1986) (Table of Contents Only).
Chater et al., “Streptomyces ØC31-Like Phages: Cloning Vectors, Genome Changes and Host Range,” inSixth International Symposium on Actinomycetes Biology, edited by Szabe et al., Akademiai Kaido, Budapest, Hungary, pp. 45-52 (1986).
Chen and Okayama, “High-Efficiency Transformation of Mammalian Cells by Plasmid DNA,”Molecular and Cellular Biology7(8):2745-2752 (1987).
Chomczynski and Sacchi, “Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction,”Analytical Biochemistry162:156-159 (1987).
Chu et al., “Electroporation for the efficient transfection of mammalian cells with DNA,”Nucleic Acids Research15:1311-1326 (1987).
Curiel et al., “Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated Endocytosis Pathway,”Am. J. Respir. Cell. Mol. Biol. 6:247-252 (1992).
Curtin et al., “Inhibition of the growth of human hepatocellular carcinomain vitroand in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717,”Br. J. Cancer53:361-368 (1986).
Dolle et al., “5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a Potent and Selective Inhibitor of Human Vascular—Type Platelet-Derived Growth Factor Receptor TyrosineKinase,”J. Med. Chem. 37:2627-2629 (1994).
Dong et al., “Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activity,”Journal of Leukocyte Biology53:53-60 (1993).
Dong et al., “Protein Tyrosine Kinase Inhibitors Decrease Induction of Nitric Oxide Synthase Activity in Lipopolysaccharide-Responsive and Lipopolysaccharide-Nonresponsive Murine Macrophages,”The Journal of Immunology151(5):2717-2724 (1993).
Dreborg et al., “Ch. 10—The chemistry and standardizati
Jallal Bahija
Plowman Gregory D.
Benson Gregg C.
Burrous Beth A.
Canella Karen A.
Slepchuk, Jr. Nicholas I.
Sugen Inc.
LandOfFree
Diagnosis and treatment of PTP related disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis and treatment of PTP related disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of PTP related disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3718056